Characterization of Glucokinases from Pathogenic Free-Living Amoebae

Jillian E Milanes1, Jimmy Suryadi1, Neil P Monaghan1

  • 1Eukaryotic Pathogens Innovation Center, Department of Genetics and Biochemistry, Clemson Universitygrid.26090.3d, Clemson, South Carolina, USA.

Insights

Pathogenic free-living amoebae infections are deadly due to CNS involvement and lack of treatments. This study investigated Acanthamoeba castellanii (AcGlck) and Balamuthia mandrillaris (BmGlck) glucokinases as potential drug targets.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Parasitology

Background:

  • Infections by pathogenic free-living amoebae (FLA) like Naegleria fowleri, Acanthamoeba spp., and Balamuthia mandrillaris cause severe central nervous system disease.
  • Current treatments for FLA infections are limited, leading to high mortality rates.
  • Targeting essential metabolic pathways, such as glucose metabolism, presents a potential therapeutic strategy.

Purpose of the Study:

  • To characterize the glucokinase enzymes from Acanthamoeba castellanii (AcGlck) and Balamuthia mandrillaris (BmGlck).
  • To compare the kinetic properties of AcGlck and BmGlck with each other and with human glucokinase (HsGlck).
  • To assess the potential of AcGlck and BmGlck as targets for novel anti-amoebic therapies.

Main Methods:

  • Enzyme kinetics assays were performed to determine kinetic parameters (Km values) for ATP and glucose.
  • Apparent Km values for ATP and glucose were measured for AcGlck, BmGlck, and HsGlck.
  • Sensitivity of AcGlck and BmGlck to small molecule inhibitors was evaluated.

Main Results:

  • AcGlck and BmGlck share 49.3% amino acid identity but exhibit distinct kinetic properties.
  • Both AcGlck and BmGlck have significantly higher apparent affinity for glucose compared to HsGlck.
  • AcGlck and BmGlck show differential sensitivity to small molecule inhibitors, complicating the development of pan-amoebic drugs.

Conclusions:

  • Glucokinases from Acanthamoeba and Balamuthia are viable targets for anti-amoebic drug development.
  • Differences in kinetic properties and inhibitor sensitivity between AcGlck, BmGlck, and HsGlck offer opportunities for selective targeting.
  • Developing inhibitors with broad activity against multiple FLA glucokinases may be challenging due to enzyme variations.

Related Concept Videos

Diversity of Protists I01:15

Diversity of Protists I

Excavata is a diverse group of protists that includes both chemoorganotrophic and phototrophic species, with some thriving in anaerobic environments. Among the key groups within Excavata are diplomonads and parabasalids, which are flagellated protists that lack mitochondria and chloroplasts. These microorganisms typically inhabit anoxic environments, such as the intestines of animals, where they exist either symbiotically or as parasites, relying on fermentation for energy production. Some...
167
Diversity of Protists IV01:27

Diversity of Protists IV

Amoebozoa represent a diverse group of terrestrial and aquatic protists that utilize lobe-shaped pseudopodia for locomotion and feeding. This characteristic differentiates them from the Rhizaria, which possess threadlike pseudopodia. The primary classifications within Amoebozoa include gymnamoebas, entamoebas, and the plasmodial and cellular slime molds. Phylogenetic evidence indicates that Amoebozoa diverged from a lineage that ultimately gave rise to fungi and animals.Gymnamoebas and...
147
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
134
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.7K